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Background: During the viremic phase of human immunodeﬁciency virus type-1 (HIV-1) infection,
hepatocytes are likely to be constantly exposed to circulating virions. Knowing that a contact between
hepatocytes and CD4+ T lymphocytes is favoured by the local slow blood ﬂow present within the liver, we
hypothesize that hepatic cells can act as a viral reservoir and thus contribute to HIV-1 propagation.
Results: We report that human hepatoma cells bind and internalize HIV-1 particles. Infection of CD4+ T cells
was found to be much more efﬁcient following a contact with virus-loaded hepatocytes than with cell-free
virus. Additional studies suggest that infection of CD4+ T cells in trans with hepatocytes carrying virus is
primarily due to surface bound HIV-1 particles and relies on LFA-1/ICAM-1 interactions.
Conclusion: This work represents the ﬁrst demonstration by which circulating CD4+ T cells can be potentially
infected with HIV-1 through a contact with hepatocytes in the liver.© 2009 Elsevier Inc. All rights reserved.Introduction
The introduction of highly active antiretroviral therapy (HAART) in
1996 has led to a dramatic decline in human immunodeﬁciency virus
type 1 (HIV-1)-associated mortality in developed countries. In those
regions, liver-related morbidity is the most frequent non-AIDS-
related cause of deaths among HIV-1-infected patients partly because
of the high rates of chronic viral hepatitis and alcohol misuse (Weber
et al., 2006). Interestingly, results from the Data Collection on Adverse
Events of Anti-HIV Drugs (DAD) study indicate that there is a strong
correlation between HIV-1-mediated immunosuppression and the
risk of liver-related death, therefore suggesting that pathogenic
mechanisms promoting T-cell depletion may also trigger liver injury
by causing an impairment of liver immunity (Weber et al., 2006).
The liver is an anatomically and immunologically unique organ
where the blood from the systemic circulation and the gastrointes-
tinal tract is ﬁltered through hepatic sinusoids. The sinusoidal
endothelium differs from the other capillaries in the body by the
presence of numerous fenestrations and the lack of basal lamina
under the endothelium (Wisse et al., 1985). The small diameter of thes, analyzed the data and wrote
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ll rights reserved.sinusoids and the slow rate of blood ﬂow prolong the contact between
immune and endothelial cells (Wong et al., 1997). This phenomenon,
in addition to the special architecture of the fenestrated sinusoidal
endothelium, facilitates extravasation of T lymphocytes through this
organ (Warren et al., 2006). The liver is constantly exposed to a
variety of antigens derived from the gastrointestinal tract and
systemic circulation, including dietary antigens, pathogens and toxins.
Those antigens are efﬁciently sensed by a variety of innate immune
cells residing in the liver, such as macrophages (better known as
Kupffer cells), immature dendritic cells (iDCs), natural killer (NK) and
NKT cells (Racanelli and Rehermann, 2006). Although adaptive
immune cells like CD4+ and CD8+ T lymphocytes can be found
scattered in the portal tract, themost important pool of T lymphocytes
interacting with liver cells originate from the bloodstream or the
gastrointestinal tract (Shetty et al., 2008).
HIV-1 is known to productively infect CD4+ T cells in different
ways. Increasing interest is focused on the cell-to-cell spreading that,
for HIV-1, constitutes a more potent mode of virus propagation than
following infection with cell-free virus (Dimitrov et al., 1993).
Several studies have demonstrated that cell-to-cell HIV-1 transmis-
sion can occur with the help of various carrier cells, including CD4-
positive cells such as macrophages and iDCs (Carr et al., 1999;
Geijtenbeek et al., 2000), but also CD4-negative cells such as B
lymphocytes (De Milito, 2004), neutrophils, erythrocytes (Olinger
et al., 2000), epithelial (Asin et al., 2004; Giacaman et al., 2008; Meng
et al., 2002;Mikulak et al., 2009) and endothelial cells (Thibault et al.,
2007). Obviously, productive infection of these carrier cells is not
required for trans infection of susceptible target CD4+ T cells. Given
their anatomical location and their role in acute HIV-1 infection,most
of the trans infection studies have been done with iDCs. Although it
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particles by endocytosis to later deliver them to permissive cells via
vesicular exocytosis, recent ﬁndings suggest that themajority of HIV-
1 transmitted in trans originate from the plasma membrane (Cavrois
et al., 2008, 2007) and more precisely from membrane invaginations
(Yu et al., 2008).
In the present work, we were interested in determining whether
liver cells could, like the above-mentioned cell types (e.g. iDCS),
contribute to trans infection of CD4+ T cells by HIV-1. Hepatocytes
constitute about two thirds of the total cell population in the liver,
where they are involved in many biological processes. To favour
exchangewith the blood, hepatocytes bearmultiple surfacemicrovilli.
During viremic phases of HIV-1 infection, hepatocytes are expected to
be frequently exposed to very large quantities of virus through the
hepatic blood ﬂow. Unfortunately, very few published studies can be
found in the literature that relate to the possible interaction between
HIV-1 and hepatocytes. Two previous works have described by in situ
hybridization the presence of HIV-1 RNA and proteins in hepatocytes
from liver biopsies of HIV-1-infected patients (Cao et al., 1992;
Housset et al., 1993). Since hepatocytes are negative for CD4, the
primary cellular receptor for HIV-1, and express a barely detectable
level of coreceptors CXCR4 and CCR5 (unpublished data), it is thus not
surprising to observe that this cell type is weakly susceptible to
productive infection with this retrovirus (manuscript in preparation).
However, like epithelial cells (Bomsel and Alfsen, 2003), hepatocytes
could express other cell surface molecules promoting HIV-1 capture.
Therefore, we hypothesized that interactions between virus and
hepatocytes could contribute to HIV-1 pathogenesis by facilitating
CD4+ T cells infection during their passage into the liver. In this study,
we ﬁrst investigated the ability of human hepatoma cells to absorb
and internalize HIV-1 particles. Next, we studied whether those viralFig. 1.Human hepatoma cells harbor HIV-1 particles. (A) Huh7.5 cells were exposed to NL4-3
estimate virus binding) or 37 °C (to estimate virus internalization). The cells were then t
measured by evaluating the amount of p24 in each cell lysate and are expressed as percent
mean (SEM) of data from triplicate samples of 4 independent experiments. (B) Huh7.5 cells w
37 °C for indicated times. The amount of hepatocyte-associated virus was quantiﬁed by estim
shown are means±SEM of data from triplicate samples of a single experiment representatparticles can be efﬁciently transmitted to CD4+ T cells, and
characterized the mechanism underlying the phenomenon.
Results
HIV-1 particles are captured and internalized inside human hepatoma
cells, and persist therein for up to 3 days
We ﬁrst set out to determine whether hepatocytes can capture
virions which will ultimately remain infectious for a subsequent
transfer toward susceptible target cells. For this purpose, we ﬁrst
evaluated if the human hepatoma Huh7.5 cells were able to bind and
internalize X4- (i.e. NL4-3) and R5-tropic variants (i.e. NL4-3Balenv).
For the binding assay, viral exposure was performed for varying time
lengths at 4 °C to prevent endocytosis of viral particles. Treatment of
cells with pronase after viral binding at 4 °C conﬁrmed that HIV-1 is
unable to enter inside hepatocytes at this temperature (data not
shown). The possible internalization of HIV-1 within Huh7.5 was
evaluated using an incubation step at 37 °C followed by a trypsin
proteolysis to remove uninternalized virus. As shown in Fig. 1A,
human hepatoma cells can efﬁciently bind and internalize both X4-
and R5-using virus in a time-dependent manner. A dose-dependent
increase in virus attachment was seenwhen using escalating amounts
of both NL4-3 (X4-using) and NL4-3Balenv virons (R5-tropic) (i.e.
virus input of 5, 10, 20, 50 and 100 ng of p24) (data not shown).
Additional experiments were performed also with an Env-deﬁcient
virus with similar results (data not shown), therefore indicating that
the external Env glycoprotein 120 (gp120)was not necessary for virus
binding and internalization in Huh7.5 cells.
Next we wanted to estimate how long viral particles can remain
attached/internalized in hepatocytes before their degradation. To this(left panel) or NL4-3Balenv (right panel) for the indicated time periods either at 4 °C (to
reated as described in Materials and methods. Viral binding and internalization were
ages of the initial p24 input. Results depicted represent means±standard errors of the
ere exposed to NL4-3 or NL4-3Balenv for 2 h at 37 °C, washed with PBS and then left at
ating the p24 content and is expressed as percentages of the initial p24 input. Results
ive of 2.
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HIV-1 degradation in hepatocytes by assessing the p24 content after
removal of the unbound viruses by extensive washes with PBS to
eliminate unadsorbed virions. Most of the viral degradation was
observed during the ﬁrst 4 h (Fig. 1B). However, virus remains
detectable for as long as 72 h. These results suggest that a certain
amount of viral particles can remain associated with hepatocytes
either at the cell surface or intracellularly for at least 3 days.
Hepatocyte-associated virus is efﬁciently transmitted to CD4+ T cells
Given that HIV-1 can be bound and internalized inside hepato-
cytes, our next step was to examine if such hepatocyte-associated
virus can be efﬁciently transferred to susceptible CD4+ T cells. To
answer this question, activated CD4+ T cells were exposed for 1 h at
37 °C to HIV-1-pulsed hepatocytes as described in Materials and
methods. Trans infection of permissive CD4+ T cells occurred when
Huh7.5 cells were ﬁrst exposed to X4 and R5 virions (Fig. 2A). An
efﬁcient hepatocyte-mediated transfer of HIV-1 was seen when using
another human hepatoma cell line (i.e. HepG2) (data not shown).
Since hepatocyte-associated HIV-1 can persist for at least 72 h, we
wondered whether those virions are still infectious and can be
transmitted to susceptible CD4+ T cells. To answer this fundamental
question, Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv (30 ng
of p24 per 1×105 cells) for 2 h at 37 °C, washed twice with PBS and
left at 37 °C for the listed periods of time (i.e. from 0 to 72 h). In order
to remove free virus released during the incubation time, hepatocytes
were washed once with PBS before addition of activated CD4+ T cells.
Data depicted in Fig. 2B indicate that hepatocyte-associated NL4-3
and NL4-3Balenv remain infectious for 2 and 3 days, respectively.
Taken together, our results suggest that human hepatocytes can trap
HIV-1 particles, keeping them infectious for at least 48 h and transfer
them to permissive CD4+ T cells.Fig. 2.Hepatocytes transmit infectious virus to activated CD4+ T cells. Huh7.5 cells were expo
cells were immediately co-cultured with activated CD4+ T cells for 1 h at 37 °C (A) or left at 3
37 °C (B). Next, CD4+ T cells were removed and cultured alone. Virus production was monit
virus infection (B) (NL4-3: left panel; NL4-3Balenv: right panel). Data depicted represent the
donors.Hepatocyte-mediated trans infection is more efﬁcient than cell-free
virus infection
We next evaluated whether transfer through hepatocytes results in
stronger viral infection of CD4+ T cells than infection by cell-free
virions, as it is known to be the case with macrophages (Carr et al.,
1999). To compare efﬁciency of trans infection (hepatocytes-associated
virus) with that of direct infection (cell-free virus) of activated CD4+ T
cells, the amount of hepatocyte-captured viruses available for trans
infection, after 2 h of pulsing, was determined by the p24 assay. This
same quantity was used to directly infect CD4+ T cells. As shown in
Fig. 3, infection of CD4+ T cells with hepatocyte-associated virus is
enhanced by about 100-fold for NL4-3 and 50-fold for NL4-3Balenv, as
compared to infection with a similar amount of cell-free virions.
Studies were next performed to determinewhether the coculture step
leads to activation of CD4+ T cells, which could eventually enhance
HIV-1 replication. Flow cytometry analyses of activation markers on
the surface of CD4+ T cells (i.e. HLA-DR and CD39) either cultured
alone or cocultured with Huh7.5 cells indicate that the coculture step
does not further activate CD4+ T cells (data not shown).
Trans infection by hepatocytes is due to transmission of virus associated
with the plasma membrane
As previously described for DCs, which is the typical cell type used
to deﬁne trans infection process also known as the “Trojan horse”
model, the virus involved in trans infection could originate either
from plasma membrane or intracellular vesicles (Cameron et al.,
1992; Geijtenbeek et al., 2000). To discriminate between these two
distinct origins, Cavrois et al. (2007) used sCD4, a virus-speciﬁc
membrane-impermeable inhibitor, to neutralize viruses bound onto
the plasma membrane without affecting those located inside
intracellular compartments. A similar experimental procedure wassed to NL4-3 or NL4-3Balenv for 2 h at 37 °C. After PBSwashes to remove unbound virus,
7 °C for indicated times prior to being co-cultured with activated CD4+ T cells for 1 h at
ored either at 2 days post-infection (dpi) (A) or at the indicated time periods following
means±SEM of quadruplicate samples from a single donor representative of 3 different
Fig. 3. Infection of CD4+ T cells is more efﬁcient with hepatocyte-associated virus than cell-free virus. Huh7.5 cells were exposed to NL4-3 (left panel) or NL4-3Balenv (right panel)
for 2 h at 37 °C. After PBS washes to remove unbound virus, activated CD4+ T cells were co-cultured with virus-pulsed Huh7.5 cells or inoculated with a similar amount of cell-free
virus for 1 h at 37 °C. In the case of co-cultured cells, CD4+ T cells were removed and maintained in culture alone. Virus production was monitored at 2 dpi. Data depicted represent
the mean±SEM of quadruplicate samples from a single donor and are representative of 3 different donors. Statistical analysis was performed on the results from all experiments.
Asterisks denote statistically signiﬁcant difference (⁎pb0.05).
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sCD4 is sufﬁcient to prevent trans infection of CD4+ T cells by
hepatocyte-associated virions. Importantly, the efﬁciency of sCD4
neutralization was similar for X4- and R5-tropic viruses (respectively
95±3 and 97±1 percent inhibition, calculated with data collected
from 3 different donors and express as mean±SEM). Altogether our
ﬁndings demonstrate that virions transmitted in trans originate from
the plasma membrane of Huh7.5 cells and not from intracellular
vesicles.
ICAM-1/LFA-1 interactions are involved in hepatocyte-mediated trans
infection of CD4+ T cells
Cell-to-cell interactions mediated by intercellular adhesion mole-
cule-1 (ICAM-1) and leukocyte function-associatedmolecule-1 (LFA-1)
have been proposed to be important for HIV-1 transmission from DCs
(Wang et al., 2009) or CD4-negative cells (Olinger et al., 2000). The
possible involvement of ICAMs/LFA-1 interactions in the hepatocyte-
mediated transfer of HIV-1 was thus investigated by ﬁrst assessing
surface expression of ICAMmolecules inHuh7.5 cells byﬂowcytometry.
We observed that these cells express high levels of ICAM-1 but areFig. 4.HIV-1 particles transmitted in trans originate from the plasmamembrane of hepatocyt
and either left untreated or treated for 1 h at 4 °C with sCD4 (20 μg/ml). After PBS washes, a
allow trans infection. Next, CD4+ T cells were removed and cultured alone. Virus prod
quadruplicate samples from a single donor at 2 dpi and are representative of 3 different dono
analysis was performed on the results from all experiments. Asterisks denote statistically snegative forboth ICAM-2and -3 (Fig. 5A).However, as expected,Huh7.5
cells donot express LFA-1 (datanot shown).Next, activatedCD4+Tcells
were incubated with a neutralizing monoclonal antibody against LFA-1
(i.e. MEM-25) before performing a trans infection experiment as
described above. As shown in Fig. 5B, the presence of the blocking
anti-LFA1 antibody before initiation of the co-culture step resulted in a
marked diminution in the hepatocyte-dependent transmission of HIV-1
toward CD4+ T cells (i.e. 83±9% inhibition, calculated with data
collected from3 different donors and express asmean±SEM), whereas
the isotype-matched control antibody (i.e. IgG1) displayed no inhibitory
effect. To ensure the validity of these data, similar studies were
conducted with another inhibitor, namely the LFA-1 antagonist
XVA143 as described recently (Tardif et al., 2009). A strong reduction
in hepatocyte-mediated HIV-1 trans infection of CD4+ T cells was seen
withXVA143(i.e. 71±6% inhibition, calculatedwithdata collected from
3 different donors and express asmean±SEM) (Fig. 5C). This inhibition
was dose-dependent when using concentrations ranging from 0.05 to
5 μM (data not shown). The vehicle (DMSO), used here as a control, has
no effect on trans infection. It is important to note that MEM-25 and
XVA143 were removed after the contact between HIV-1-loaded
hepatocytes and CD4+ T cells to allow cell-to-cell virus spreading.es. Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv for 2 h at 37 °C, washed with PBS
ctivated CD4+ T cells were incubated for 1 h at 37 °C with virus-pulsed hepatocytes to
uction was monitored at different dpi. Data depicted represent the mean±SEM of
rs. The kinetics of NL4-3 production over time is displayed in the small insert. Statistical
igniﬁcant difference (⁎⁎pb0.01; ⁎pb0.05).
Fig. 5. ICAM-1/LFA-1 interactions are involved in hepatocyte-mediated trans infection of activated CD4+ T cells. Expression of LFA-1 ligands (i.e. ICAM-1, -2 and -3) was veriﬁed on
surface of Huh7.5 cells by ﬂow cytometry as described in Materials andmethods (ICAM-1: continuous black line; ICAM-2: dotted line; ICAM-3: gray line; isotype-matched irrelevant
control antibody: gray under curve area). Percentage of cell surface expression of ICAM-1 is displayed on the histogram graph (A). Activated CD4+ T cells were either left untreated
or treated for 30 min at 37 °C with the blocking anti-LFA-1 monoclonal antibody MEM-25 (2.5 μg/ml) (B) or the LFA-1 antagonist XVA143 (0.5 μM) (C) before initiating a co-culture
step with virus-pulsed Huh7.5 cells. Next, CD4+ T cells were removed and cultured alone. Virus production was monitored at several dpi. Data shown represent the mean±SEM of
quadruplicate samples from a single donor at 2 dpi and are representative of 3 different donors. The kinetics of virus production over time is displayed in small inserts. Statistical
analysis was performed on the results from all experiments. Asterisks denote statistically signiﬁcant difference (⁎pb0.05).
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conﬁrmed that the studied inhibitors had been effectively removed and
that the observed effect was not caused by hindering cell-to-cell
contacts (data not shown).
Discussion
Knowing that the liver ﬁlters an average of 2,600 liters of blood
daily that contain about 108 peripheral blood lymphocytes (Wicket al., 2002) and given that hepatocytes constitute two thirds of the
total liver cell population, it can be proposed that hepatic cells are
most likely exposed to signiﬁcant amounts of circulating virus in the
context of an HIV-1 infection and may therefore contribute to some
extent to the disease pathogenesis by transmitting virions to
permissive CD4+ T cells circulating through the liver in both normal
and inﬂammatory conditions. Our in vitro studies support this
postulate since we report here that human hepatoma cell lines can
ﬁrst capture and internalize X4- and R5-tropic isolates of HIV-1 and
173R. Fromentin et al. / Virology 398 (2010) 168–175next transmit infectious particles to susceptible CD4+ T cells. In
addition, we provide evidence that acute infection of CD4+ T cells
with hepatocyte-associated virus is two orders of magnitude more
efﬁcient than infection with cell-free virus. Although hepatocytes can
internalize HIV-1 particles, a minority seems to be transferred from an
internal compartment. In fact, trans infection of CD4+ T cells with
both X4 and R5 virus is signiﬁcantly inhibited by a treatment with
sCD4 suggesting that the vast majority of the transmitted virus
originates from the plasma membrane.
This raised the issueof themodeof attachmentofHIV-1particles onto
hepatocytes, which may be multifactorial. The absence of detectable
expressionof CD4 coupledwith low levels of CXCR4andCCR5expression
on the surface of Huh7.5 cells suggest that viral binding and
internalization could be independent of gp120. This possibility was
conﬁrmed when using an Env-deﬁcient virus. Moreover unpublished
observations suggest that adsorption of viral particles may be mostly
caused by electrostatic or other undeﬁned interactions (data not shown).
Our ﬁndings also suggest that host proteins, lipids or polysaccharides
incorporated in the viral bilayer might participate in viral adsorption on
the hepatocyte cell surface. One possibility is that glycosphingolipids
anchored into the viral membrane could play a role in the attachment
process via factors recognizing thosemolecules on hepatocytes. In fact, it
has been recently described that, in absence of Env glycoproteins, HIV-1-
associated glycosphingolipids participate in the initial DC-mediated HIV-
1 capture (Hatch et al., 2009). Further investigations are required to shed
light on the precise mechanism(s) by which hepatocytes can capture
HIV-1 particles and keep them infectious for an extended time length.
Depending on the nature of attachment factors mediating HIV-1
binding, the interaction between viruses and hepatocytes can lead to
either viral degradation or viral protection, the latter one permitting the
subsequent trans infection of CD4+ T cells. In the current study, we
demonstrate that hepatocyte-associated virus can remain infectious for
at least 2 or 3 days suggesting that hepatocytes could represent a
transient HIV-1 reservoir. A number of hypotheses can be proposed to
explain how HIV-1 particles can remain infectious for a long period of
timewhile being associatedwith the plasmamembrane of hepatocytes.
It is possible that HIV-1 particles remain associated within deep
invaginations, protected from the surrounding environment, and that,
upon a physical contact with CD4+ T cells, virions are redistributed at
the cell-to-cell interface. Alternatively, viruses could travel along the
length of ﬁlopodia, which are thin actin-rich cellular extensions
functioning as antennae to sense the environment, to communicate
with other cells and to initiate cell-cell or cell-matrix adhesion (Mattila
and Lappalainen, 2008). This phenomenon has already been described
for retroviruses, including HIV-1 (Hope, 2007; Sherer and Mothes,
2008). Moreover, in non-inﬂamed states the interaction between
hepatocytes and CD4+ T cells can occur through fenestrations present
in the sinusoidal endothelium. It has been demonstrated, at least in
murine liver, that cytoplasmic extensions of hepatocytes can cross the
fenestrations and contact circulating T cells (Warren et al., 2006).
Alternatively,membrane extensions fromcirculatingT lymphocytes can
pass through the fenestrations and reach plasma membrane of
hepatocytes. In some particular conditions affecting the integrity of
the fenestrated sinusoidal liver endothelium (Braet and Wisse, 2002),
the contact between hepatocytes and T lymphocytes might be
facilitated, notably during liver infection, alcohol-induced cirrhosis, or
microbial translocation triggering endotoxin exposure (Braet and
Wisse, 2002). In any case, further studies are required to clarify where
HIV-1 particles are precisely localized on hepatocytes.
In other respects, we report that ICAM-1/LFA-1 interactions play
a dominant role in the transmission of HIV-1 from hepatocytes.
Although hepatocytes in normal tissues express low or undetect-
able levels of ICAM-1, as detected by immunohistochemistry
(Adams et al., 1991; Dustin et al., 1986), it has been reported that
proinﬂammatory cytokines and endotoxin stimulate ICAM-1 ex-
pression in hepatocytes (Satoh et al., 1994). Given that HIV-1infection is characterized by a heightened inﬂammatory state, it can
be proposed that hepatocytes in HIV-1-positive individuals do
express ICAM-1. Interestingly, expression of ICAM-1 is polarized
toward sinusoidal lumen in murine liver (Warren et al., 2006). It
can thus be postulated that the initial contact between these cells
and T lymphocytes mostly depends on ICAM-1 and its counter-
receptor on T cells, the integrin LFA-1. This adhesive interaction
plays important roles in immunity by stabilizing the association
between antigen-presenting cells and T lymphocytes and also by
mediating leukocytes migration. Moreover, the LFA-1-mediated
cell-to-cell adhesion process has been proposed to be important for
HIV-1 transmission from DCs (Sanders et al., 2002; Wang et al.,
2009) as well as from CD4-negative cells (Olinger et al., 2000) to
CD4+ T cells promoting the formation of an infectious synapse
(Martin and Sattentau, 2009). Here we show that the ICAM/LFA-1
interaction plays a dominant role in the hepatocyte-mediated HIV-1
transfer toward activated CD4+ T cells. Indeed, blocking LFA-1 on
activated CD4+ T cells either with a neutralizing monoclonal
antibody or a speciﬁc antagonist strongly impairs the hepatocyte-
mediated HIV-1 transmission.
In this study, we present for the ﬁrst time a process by which
circulating CD4+ T cell can be infected with HIV-1 in the largest organ
inside the body, i.e. the liver. Indeed, our data indicate that hepatocytes
can capture and internalize X4- and R5-tropic strains of HIV-1, and
mediate trans infection of CD4+ T cells. Moreover, the capacity of hepatic
cells to serve as a transient reservoir for HIV-1 can also affect NKT cells,
another lymphocyte subpopulation known to be enriched in the liver.
Importantly, this T cell subset was previously identiﬁed as susceptible to
productive HIV-1 infection (Motsinger et al., 2002). Three independent
studies convincingly showed that HIV-1 infection causes a signiﬁcant
reduction in NKT levels at a rate faster than that of conventional CD4+ T
cells (Motsinger et al., 2002; Sanders et al., 2002; van der Vliet et al.,
2002). Knowing that NKT cells play an important role in acute HCV
infection (Golden-Mason et al., 2007), we hypothesize that hepatic NKT
cell depletion mediated by hepatocyte-associated HIV-1 trans infection
may increase susceptibility to HCV infection. Altogether, those phenom-
ena could explain why individuals diagnosed with primary HIV-1
infection present a higher incidence of acute HCV infection (Fox et al.,
2008; Osinusi et al., 2009). Finally, our results suggest that hepatocytes
play a previously unrecognized role in HIV-1 replication in CD4+ T cells
and viral pathogenesis through a trapping mechanism.
Conclusions
In summary, this work describes for the ﬁrst time an interesting
mechanism by which circulating CD4+ T cell can be infected with HIV-1
in the liver. We demonstrate that hepatocytes are able to bind and
internalize HIV-1 particles and transmit cell surface-associated virus to
CD4+ T cells through ICAM-1/LFA-1 interactions. This cell-to-cell
infection process might facilitate viral dissemination throughout the
organism. This study highlights the need to investigate more deeply the
role of the liver in HIV-1 infection and to studymore closely co-infection
with pathogens that can target this vital organ (e.g. HCV and HBV).
Materials and methods
Cells
Human hepatoma cell lines Huh7.5 (supplied by C.M. Rice, Apath
LLC, St Louis, MO) and HepG2 (a kind gift from L. Bélanger, Centre de
recherche de l'Hôtel-Dieu de Québec, Québec, QC) were maintained
as monolayers in Dulbecco's modiﬁed Eagle's medium (DMEM)
supplemented with 10% heat-inactivated foetal bovine serum (FBS),
streptomycin (100 μg/ml), penicillin G (100 U/ml) and 0.1 mM of
non-essential amino acids (Invitrogen, Burlington, ON). Human
embryonic kidney 293T cells (ATCC, Manassas, VA) were cultured
174 R. Fromentin et al. / Virology 398 (2010) 168–175in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with
10% heat-inactivated FBS, streptomycin (100 μg/ml), penicillin G
(100 U/ml). Human primary CD4+ T cells from healthy donors were
isolated using a negative selection kit according to the manufac-
turer’s instructions (StemCell Technologies Inc., Vancouver, BC).
Puriﬁed CD4+ T cells were cultured in RPMI-1640 medium (Invitro-
gen) supplemented with 10% FBS, streptomycin (100 μg/ml),
penicillin G (100 U/ml) and were stimulated for 2 days with the
mitogenic agent phytohemagglutinin-L (PHA-L) (1 μg/ml) and
recombinant human interleukin-2 (rhIL-2) (30 U/ml) prior to their
use in co-culture studies with virus-loaded Huh7.5 cells.
Reagents and antibodies
The anti-CD11a monoclonal antibody (mAb) (clone MEM-25)
was purchased from Axxora (San Diego, CA). Anti-ICAM-2 (clone
92C12F) and anti-ICAM-3 (ICR-5.1) mAbs were supplied by ICOS
Corp. (Bothell, WA) while the anti-ICAM-1 Ab RR1/1.1.1 was kindly
provided by Robert Rothlein (Boehringer Ingelheim, Ridgeﬁeld, CT)
(Rothlein et al., 1986). Hybridomas producing 183-H12-5C and 31-
90-25, two mAbs recognizing different epitopes of the HIV-1 major
viral core protein p24, were supplied by the AIDS Repository
Reagent Program (Germantown, MD) and ATCC, respectively.
Antibodies obtained from these cells were puriﬁed using mAbTrap
protein G afﬁnity columns according to the manufacturer's
instructions (Amersham Pharmacia Biotech, Piscataway, NJ). PHA-
L was obtained from Sigma (St-Louis, MO) and rhIL-2 as well as
soluble CD4 (sCD4) were kindly supplied by the AIDS Repository
Reagent Program. The LFA-1 antagonist XVA143 was kindly
donated by Paul Gillespie (Hoffmann-La Roche Inc., Nutley, NJ).
Plasmids and production of viral stocks
Plasmids used to produce viral stocks include pNL4-3 (Adachi
et al., 1986) and pNL4-3Balenv (Dornadula et al., 1999), two full-
length infectious molecular clones of HIV-1. In pNL43Balenv, the env
gene of the X4 (T)-tropic NL4-3 strain has been replaced with that of
the R5 (macrophage)-tropic Bal strain. The NL4-3Δenv vector encodes
a complete HIV-1 genome containing a -1 frameshift in the envelope
(Env) precursor and was used to produce Env-deﬁcient viruses
(kindly provided by David E. Ott from the National Cancer Institute,
Frederick, MD). Virions were produced by transient transfection in
293T cells as previously described (Fortin et al., 1997). The virus-
containing supernatants were ﬁltered through a 0.22-μm cellulose
acetate syringe ﬁlter, ultracentrifuged in an Optima L-90K Beckman
Coulter apparatus (Fullerton, CA) for 45min at 28,000 rpm (100,000g)
in a 70 Ti rotor and normalized for virion content using a sensitive in-
house ELISA speciﬁc for the viral p24 protein. In this enzymatic assay,
183-H12-5C and 31-90-25 antibodies are used in combination to
quantify p24 levels (Bounou et al., 2002).
Virus binding and internalization experiments
Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv (10 ng of p24
per 1×105 cells) for 0–4 h at 4 °C (to test virus binding) or 37 °C (to test
virus internalization). For assessing the level of virus binding, the cells
were washed 3 times with ice-cold phosphate-buffered saline (PBS) in
order to remove free virions. To demonstrate that only virus binding is
taking place at 4 °C, the cells were subjected to a pronase treatment (i.e.
200 μg/ml for 30 min at 4 °C) following incubation with HIV-1 as
described previously (Cavrois et al., 2007). For virus internalization, the
cells were washed once with ice-cold PBS, treated with 0.05% trypsin
and 0.53 mM EDTA (Invitrogen) for 5 min at 37 °C (proteolysis was
stopped by adding an equal volume of FBS), to remove all non-
internalized viral particles, andwashed twice with ice-cold PBS. Finally,
cellswere lysed in 100 μl of lysis buffer (20mMHEPES [pH7.4], 150mMNaCl, and 0.5% Triton X-100). The amount of attached or internalized
virus was estimated by assessing the p24 content.
Virus degradation experiments
Huh7.5 cells were exposed to NL4-3 or NL4-3Balenv (30 ng of p24
per 1×105 cells) for 2 h at 37 °C, washed twice with PBS and left at
37 °C for various time periods ranging from 0 to 72 h. Cells were then
washed once with PBS and lysed in 200 μl of lysis buffer. The amount
of virus was estimated by the p24 assay.
Trans infection experiments
Adherent Huh7.5 cells or HepG2 cells (1×105 in 48-well ﬂat-
bottom tissue culture plates) were pulsed with studied virus stocks
(30 ng of p24) for 2 h at 37 °C. Cells were then washed 3 times with
ice-cold PBS to remove unbound virions and activated CD4+ T
lymphocytes were incubated together with virus-pulsed Huh7.5 cells
(3:1 ratio) for 1 h at 37 °C. Next, non-adherent CD4+ T lymphocytes
were removed from adherent Huh7.5 cells through the use of 5 mM
EDTA-PBS to disrupt cell-to-cell interactions, washed twice with PBS
and then cultured in complete RPMI-1640 medium supplemented
with rhIL-2 (30 U/ml). Cell-free supernatants (half of the medium)
were harvested at days 2, 4 or 6 following trans infection and kept
frozen at −20 °C. Virus production was estimated by measuring p24
levels in such cell-free culture supernatants.
To assess infectivity of virus located on the surface of hepatocytes,
Huh7.5 cells were pulsed as described above and left at 37 °C for
increasing time periods (i.e. from 0 to 72 h) before being used to trans
infect mitogen-activated CD4+ T lymphocytes. Cell-free supernatants
(half of themedium)were harvested at days 2, 4, 6, 8, 11 or 15 following
trans infection and kept frozen at−20 °C until p24 quantiﬁcation.
For localizing virus in hepatocytes that trans infect permissive
CD4+ T cells, experiments were performed as described above, with
the following additional step. After virus pulsing, HIV-1-loaded
Huh7.5 cells were treated with 20 μg/ml of soluble CD4 (sCD4) for
60 min at 4 °C in order to neutralized surface bound virus.
For monitoring the contribution of ICAM-1/LFA-1 interactions to
the hepatocyte-mediated virus transfer process, trans infection
studies were performed as described above, with the following
additional step. The blocking anti-LFA-1 monoclonal antibody MEM-
25 or the LFA-1 antagonist XVA143 were added to CD4+ T cells for
30 min before incubation with HIV-1-loaded Huh7.5 cells.
Comparative studies between hepatocyte-mediated trans infection and
cell-free virus infection of CD4+ T cells
To compare efﬁciency of trans (virus-loaded hepatocytes) and direct
(cell-free virus) infection of CD4+ T cells, the amount of hepatocyte-
associated virus after 2 h of pulsing was determined by the p24 assay.
This quantity (approximately 3 ng of p24) was used to achieve infection
of CD4+ T cells with cell-free virus (3×105 in 200 μl of culture medium)
for 1h at 37 °C. As for trans infection, CD4+T cellswere thenwashedwith
PBS and cultured in complete RPMI-1640 medium supplemented with
rhIL-2 (30 U/ml). Cell-free supernatants (half of the medium) were
harvested at days 2, 4 or 6 following trans infection and kept frozen at
−20 °C. Virus productionwas estimated bymeasuring p24 levels in such
culture supernatants.
Flow cytometry
Subconﬂuent Huh7.5 cells were removed by a treatment with
5 mM EDTA-PBS before performing ﬂow cytometry analyses. Cells
(1×106) were incubated with 100 μl of 10% FBS-PBS containing a
saturating amount of a monoclonal anti-ICAM-1, anti-ICAM-2, anti-
ICAM-3 or an appropriate isotype-matched irrelevant control mAb
175R. Fromentin et al. / Virology 398 (2010) 168–175(for non-speciﬁc staining) for 30 min on ice. Cells were next washed
with PBS and then incubated, when appropriate, with 100 μl of a
saturating amount of R-PE-conjugated goat anti-mouse immunoglob-
ulin G (Invitrogen) for 30 min on ice. After two washes with PBS, cells
were ﬁxed in 2% paraformaldehyde and analyzed with a cytoﬂuo-
rometer (EPICS XL, Coulter Corp., Miami, FL).
Statistical analysis
Analysis was performed by one-way analysis of variance or
matched-pair t test. P values of less than 0.05 were considered to be
statistically signiﬁcant. Computations were carried out using Graph-
Pad PRISM ® version 3.03 statistical software.
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